Serial assessments of microvascular obstruction by contrast-enhanced magnetic resonance predict contractile recovery and clinical outcome after reperfused acute myocardial infarction
Restricted accessResearch articleFirst published online May 13, 2016
Serial assessments of microvascular obstruction by contrast-enhanced magnetic resonance predict contractile recovery and clinical outcome after reperfused acute myocardial infarction
AIMS: The purpose of the study was to investigate, using cardiac magnetic resonance (CMR), the presence and time course of microvascular obstruction (MO) in patients with acute myocardial infarction (AMI), and to test its relationship with cardiac remodeling and clinical outcomes.
METHODS AND RESULTS: 53 patients with AMI and successful percutaneous reperfusion underwent CMR examination at four separate timepoints: within the first 48 hours, at 10 days, at six and twelve months after infarction. MO was quantified immediately (early imaging) and 10 minutes (late imaging) after contrast administration in each session. The extent of MO decreased from early to late imaging at both the first and the second CMR exam (p≤0.001). Early MO was absent in 18(36%) patients both at 48 hours and 10 days after AMI. At 1 year follow-up, LVEF in these patients improved to normal (median = 62% (53–70)). Early MO was present in the first but not in the second CMR in 13 (26%) patients; LVEF at one year in these patients reached a median = 52% (47–61). Finally, Early MO was present in both exams in 19 (38%) patients, who at 1 year after infarction had a LVEF of median = 49% (42–54, P≤0.001 across groups). The time course of MO was a predictor of prognosis upon Kaplan-Meier analysis (P = 0.035). The presence of MO at 10 days after AMI was associated with a higher risk of MACE during a 5-years follow-up.
CONCLUSIONS: The presence of MO within 48 hours after AMI, and its time course in the following ten days, provides complementary information on both functional myocardial recovery and long-term outcome.
AlpertJ.S., et al., Myocardial infarction redefined–a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction, J Am Coll Cardiol36(3) (2000), 959–969.
2.
BekkersS.C., et al., Detection and characteristics of microvascular obstruction in reperfused acute myocardial infarction using an optimized protocol for contrast-enhanced cardiovascular magnetic resonance imaging, Eur Radiol19(12) (2009), 2904–2912.
3.
BogaertJ., et al., Determinants and impact of microvascular obstruction in successfully reperfused ST-segment elevation myocardial infarction. Assessment by magnetic resonance imaging, Eur Radiol17(10) (2007), 2572–2580.
4.
BulteC.S., et al., Contrast-enhanced ultrasound for myocardial perfusion imaging, Anesth Analg114(5) (2012), 938–945.
5.
CochetA.A., et al., Major prognostic impact of persistent microvascular obstruction as assessed by contrast-enhanced cardiac magnetic resonance in reperfused acute myocardial infarction, Eur Radiol19(9) (2009), 2117–2126.
6.
CottinY., et al., MR imaging of the heart in patients after myocardial infarction: Effect of increasing intersection gap on measurements of left ventricular volume, ejection fraction, and wall thickness, Radiology213(2) (1999), 513–520.
7.
de WahaS., et al., Impact of early vs. late microvascular obstruction assessed by magnetic resonance imaging on long-term outcome after ST-elevation myocardial infarction: A comparison with traditional prognostic markers, Eur Heart J31(21) (2010), 2660–2668.
8.
DeweyM., et al., Myocardial viability: Assessment with three-dimensional MR imaging in pigs and patients, Radiology239(3) (2006), 703–709.
9.
GerberB.L., et al., Microvascular obstruction and left ventricular remodeling early after acute myocardial infarction, Circulation101(23) (2000), 2734–2741.
10.
GrinesC.L., et al., Coronary angioplasty with or without stent implantation for acute myocardial infarction. Stent Primary Angioplasty in Myocardial Infarction Study Group, N Engl J Med341(26) (1999), 1949–1956.
11.
HombachV., et al., Sequelae of acute myocardial infarction regarding cardiac structure and function and their prognostic significance as assessed by magnetic resonance imaging, Eur Heart J26(6) (2005), 549–557.
12.
ItoH., et al., Clinical implications of the ‘no reflow’ phenomenon. A predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction, Circulation93(2) (1996), 223–228.
13.
ItoH., et al., Lack of myocardial perfusion immediately after successful thrombolysis, A predictor of poor recovery of left ventricular function in anterior myocardial infarction, Circulation85(5) (1992), 1699–1705.
14.
JaffeR., et al., Microvascular obstruction and the no-reflow phenomenon after percutaneous coronary intervention, Circulation117(24) (2008), 3152–3156.
15.
KimR.J., et al., Myocardial Gd-DTPA kinetics determine MRI contrast enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction, Circulation94(12) (1996), 3318–3326.
16.
KlonerR.A., GanoteC.E. and JenningsR.B., The “no-reflow” phenomenon after temporary coronary occlusion in the dog, J Clin Invest54(6) (1974), 1496–1508.
17.
KondoM., et al., Assessment of “microvascular no-reflow phenomenon” using technetium-99m macroaggregated albumin scintigraphy in patients with acute myocardial infarction, J Am Coll Cardiol32(4) (1998), 898–903.
18.
LardoA.C., et al., Contrast-enhanced multidetector computed tomography viability imaging after myocardial infarction: Characterization of myocyte death, microvascular obstruction, and chronic scar, Circulation113(3) (2006), 394–404.
19.
LombardoA., et al., Impact of microvascular obstruction and infarct size on left ventricular remodeling in reperfused myocardial infarction: A contrast-enhanced cardiac magnetic resonance imaging study, Int J Cardiovasc Imaging (2011)–.
20.
LundG.K., et al., Acute myocardial infarction: Evaluation with first-pass enhancement and delayed enhancement MR imaging compared with 201Tl SPECT imaging, Radiology232(1) (2004), 49–57.
21.
MolletN.R., et al., Visualization of ventricular thrombi with contrast-enhanced magnetic resonance imaging in patients with ischemic heart disease, Circulation106(23) (2002), 2873–2876.
22.
NijveldtR., et al., Assessment of microvascular obstruction and prediction of short-term remodeling after acute myocardial infarction: Cardiac MR imaging study, Radiology (2009).
23.
PetersenS.E., et al., Influence of contrast agent dose and image acquisition timing on the quantitative determination of nonviable myocardial tissue using delayed contrast-enhanced magnetic resonance imaging, J Cardiovasc Magn Reson6(2) (2004), 541–548.
24.
PinedaV., et al., No-reflow phenomenon in cardiac MRI: Diagnosis and clinical implications, AJR Am J Roentgenol191(1) (2008), 73–79.
25.
RaffG.L., et al., Microvascular obstruction and myocardial function after acute myocardial infarction: Assessment by using contrast-enhanced cine MR imaging, Radiology240(2) (2006), 529–536.
26.
ReffelmannT. and KlonerR.A., The “no-reflow” phenomenon: Basic science and clinical correlates, Heart87(2) (2002), 162–168.
27.
RochitteC.E., et al., Magnitude and time course of microvascular obstruction and tissue injury after acute myocardial infarction, Circulation98(10) (1998), 1006–1014.
28.
SheehanF.H., et al., Early recovery of left ventricular function after thrombolytic therapy for acute myocardial infarction: An important determinant of survival, J Am Coll Cardiol12(2) (1988), 289–300.
29.
SimonettiO.P., et al., An improved MR imaging technique for the visualization of myocardial infarction, Radiology218(1) (2001), 215–223.
30.
TarantiniG., et al., Influence of transmurality: Infarct size, and severe microvascular obstruction on left ventricular remodeling and function after primary coronary angioplasty, Am J Cardiol98(8) (2006), 1033–1040.
31.
VosselerM., et al., Area at risk and viability after myocardial ischemia and reperfusion can be determined by contrast-enhanced cardiac magnetic resonance imaging, Eur Surg Res43(1) (2009), 13–23.
32.
WeirR.A., et al., Microvascular obstruction remains a portent of adverse remodeling in optimally treated patients with left ventricular systolic dysfunction after acute myocardial infarction, Circ Cardiovasc Imaging3(4) (2010), 360–367.
33.
WuK.C., et al., Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction, Circulation97(8) (1998), 765–772.
